RougeTx develops gene therapy solutions aimed at treating genetic disorders. Its innovative approach focuses on gene editing and therapy, serving the biotech industry.
Total Funding
Tens of millions
Total Rounds
1
First Raise
Oct 6, 2026
Latest Raise
Oct 6, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/6/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free